NCT00464685 Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT00462787 Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia Status COMPLETED Phase PHASE1
NCT00458822 Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis Status COMPLETED Phase PHASE2
NCT00458705 Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00457678 Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself Status WITHDRAWN Phase PHASE2
NCT00452569 Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT00452062 Dexamethasone and the Prevention of Post-Extubation Airway Obstruction in Adults Status UNKNOWN Phase PHASE2
NCT00451594 High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP Status COMPLETED Phase PHASE3
NCT00445692 Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00441168 Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma Status TERMINATED Phase PHASE2
NCT00440726 Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE1/PHASE2
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Status TERMINATED Phase PHASE1/PHASE2
NCT00438841 Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma Status UNKNOWN Phase PHASE2
NCT00437229 A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults Status COMPLETED Phase PHASE1
NCT00433537 Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00431990 A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma Status UNKNOWN Phase PHASE1/PHASE2
NCT00430118 Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE3
NCT00427999 Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00426101 Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004 Status COMPLETED Phase PHASE3